Do we treat mycoplasma pneumoniae infections differently during an epidemic?

Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tatjana Mrvic, Darja Keše, Rok Kogoj

Source: International Congress 2015 – Treatment and control of respiratory disease
Session: Treatment and control of respiratory disease
Session type: Thematic Poster Session
Number: 4063
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tatjana Mrvic, Darja Keše, Rok Kogoj. Do we treat mycoplasma pneumoniae infections differently during an epidemic?. Eur Respir J 2015; 46: Suppl. 59, 4063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mycoplasma pneumoniae infections in a paediatric setting; changes in epidemiology and clinical presentation
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Is doxycycline the right choice to treat an acute respiratory chlamydia psittaci infection?
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013

High prevalence of resistant bacterial infections in patients with tracheostomy due to neuromuscular disease (NMD)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013


Resistance of respiratory isolates of klebsiella pneumoniae from patients in pediatric cardiac surgery department
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Prevalence of group A β-haemolytic streptococcus among children with pharyngitis in Ethiopia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Emerging macrolide-resistant mycoplasma pneumoniae in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

How dangerous are respiratory tract infections with enterovirus D68?
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015


Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020




Common organisms causing community acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Extended-spectrum-beta-lactamase producing multidrug resistant nosocomial bacterial isolates causing lower respiratory tract infection in Tertiary Care Hospital, Nepal
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



Clinical impact of rhinovirus infections in infancy
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013

Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004

Do school holidays affect adult pneumococcal community acquired pneumonia incidence?
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016